Details for 2019842679

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINIERTE HBV-THERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019842679

EP Publication Number

3897672

E-Number

1596712

Language

PCT Number

US19067643

Publication Date

27.10.2021 A

09.08.2023 B1

Registration Date

09.08.2023

AT Publication Date

15.08.2023

Application Date

19.12.2019

Registration Number

Priorities

20.12.2018

201862782896 P

IPC

A61K 31/713 20060101AFI20200701BHEP

Maximum Duration of Protection

19.12.2039

Owner

VIR Biotechnology, Inc.1800 Owens Street, Suite 900 San Francisco, CA 94158US

Humabs Biomed SAVia dei Gaggini, 3 6500 BellinzonaCH

Representative

Torggler & Hofmann Patentanwälte GmbH & Co KGWilhelm-Greil-Straße 16/46020 InnsbruckAT

Inventor

BAKARDJIEV, Annac/o Vir Biotechnology, Inc. 499 Illinois, Suite 500 San Francisco, California 94158US

PANG, Phillip S.c/o Vir Biotechnology, Inc. 499 Illinois, Suite 500 San Francisco, California 94158US

CORTI, Davidec/o Humabs BioMed SA Via dei Gaggini 3 6500 BellinzonaCH

Information about Fees